Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
17 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/17/3063424/0/en/Following-FDA-Compassionate-Use-Approval-for-Pancreatic-Carcinoma-with-Can-Fite-s-Namodenoson-Leading-U-S-Medical-Centers-Seek-Authorization-for-their-Patients.html
14 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/14/3061206/0/en/Can-Fite-Announces-3-0-Million-Registered-Direct-Offering-of-American-Depositary-Shares.html
14 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/14/3060926/0/en/Can-Fite-to-Generate-685M-in-Projected-Future-Revenues-from-its-Partnerships.html
14 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/14/3060875/0/en/Can-Fite-Reports-2024-Financial-Results-and-Clinical-Update.html
24 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/24/3047925/0/en/Can-Fite-Initiates-Pivotal-Phase-3-Psoriasis-Study-of-its-Oral-Drug-Piclidenoson-with-FDA-EMA-Approved-Protocol.html
20 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/20/3046342/0/en/Can-Fite-Partner-Vetbiolix-Accelerate-Piclidenoson-Development-with-Advanced-Clinical-Trial-for-Canine-Osteoarthritis-in-a-3-8-Billion-Market.html
ABOUT THIS PAGE